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Abstract
People living in urban slums or informal settlements are among the most vulnerable commu-
nities, highly susceptible to coronavirus disease 2019 (COVID-19) infection and vulnerable to
the consequences of the measures taken to control the spread of the virus. Fear and stigma
related to infection, mistrust between officials and the population, the often-asymptomatic
nature of the disease is likely to lead to under-reporting. We conducted a cross-sectional
study to determine the seroprevalence of COVID-19 infection in a large slum in South
India 3 months after the index case and recruited 499 adults (age >18 years). The majority
(74.3%) were females and about one-third of the population reported comorbidities. The over-
all seroprevalence of IgG antibody for COVID-19 was 57.9% (95% CI 53.4–62.3). Age, edu-
cation, occupation and the presence of reported comorbidities were not associated with
seroprevalence (P-value >0.05). Case-to-undetected-infections ratio was 1:195 and infection
fatality rate was calculated as 2.94 per 10 000 infections. We estimated seroprevalence of
COVID-19 was very high in our study population. The focus in this slum should shift
from infection prevention to managing the indirect consequences of the pandemic. We rec-
ommend seroprevalence studies in such settings before vaccination to identify the vulnerabil-
ity of COVID-19 infection to optimise the use of insufficient resources. It is a wake-up call to
societies and nations, to dedicate paramount attention to slums into recovery and beyond – to
build, restore and maintain health equity for the ‘Health and wellbeing of all’.
Introduction
Coronavirus disease 2019 (COVID-19) is a pandemic of historic significance characterised by
its ubiquitous presence, accelerated expansion and catastrophic economic consequences.
Globally, over a few months of the pandemic outbreak, India became one of the epicentres
of this contagion, contributing to one-sixth of the world’s reported cases [1]. ‘Slums’ or ‘infor-
mal settlements’ which are home to at least 5.4% (65.5 million) of India’s population, paint the
most vulnerable landscape for COVID-19 infections, both in terms of susceptibility and con-
sequences [2].
Devarajeevanahalli (DJ Halli), also known as the ‘Dharavi of Bangalore’ is one of the largest
governments notified slums in Bangalore, extending over 1.15 km2 with an estimated popula-
tion of 100 000 people [3–5] (Fig. 1). The Bangalore Baptist Hospital (BBH) has been render-
ing primary care services in this slum for the past decade. BBH supported the DJ Halli
population and complemented government efforts by continuing primary health services
throughout the pandemic when all other private hospitals in the area closed owing to high
risk of infection in slums [6, 7]. Because DJ Halli is a typical slum with a likelihood of
rapid contagion, the official data of less than 295 cases and 17 deaths, 5 months past the
first case, sounded unrealistic [8, 9]. Poor cooperation with the state government’s testing
efforts was a reality as the people in DJ Halli did not trust the government’s welfare motives
after parliament passed the Citizenship Amendment Act, 2019 [10, 11]. Further, screening and
testing efforts were hindered by communal violence which claimed three lives in this area [12].
At this time, officials, public health experts and healthcare providers were not clear about
the infection status of the slum. One side argued that effective campaigns curtailed infection in
the slums and the other group postulated high rate of asymptomatic infection. Both arguments
were plausible and needed different resource allocation: for low infection rate and high suscep-
tibility, our response should be COVID-19 specific and for high infection and herd immunity,
our response should gear towards resource re-allocation to other diseases and damages caused
by COVID-19 crisis.
Though challenging, investigating the seroprevalence of
COVID-19 in DJ Halli slum was critical for us to plan the health
and social interventions in this slum. Since there is a lack of infor-
mation regarding the seroprevalence in slums, the study will add
to the body of evidence – to help city health officials locally and
public health scientists globally.
The objective of the current study was to estimate the sero-
prevalence of COVID-19 infection in a dense slum of South
India. We hypothesised a high prevalence of infection, consider-
ing the density of the population and the impossibility of prevent-
ive measures in this setting.
Materials and methods
Study design and sample size
We designed a cross-sectional seroepidemiological survey in DJ
Halli slum based on the recommendation of WHO as the most
appropriate study design after the peak transmission is established
[13]. A study from slums in Mumbai, India, has reported a sero-
prevalence of 57% [14]. We used the formulae 4 Pq/d2 and calcu-
lated a minimum sample size of 470 with an absolute precision of
5% and a design effect of 1.2.
Data collection
DJ Halli consists of two wards (administrative blocks), each of
which was further divided into four clusters for sampling pur-
poses. A kiosk was set up in one of the trusted community spaces
in each cluster. Our community health workers invited people
(adults ⩾18 years) from houses to give blood samples. If a house-
hold refused to participate, then the next house was approached.
In each cluster, mobilisation continued till the desired sample size
was achieved. We explained the purpose of the study, took written
consent and interviewed people with a questionnaire. The ques-
tionnaire contained questions about demographic information
(age, gender, education, comorbidities such as diabetes, hyperten-
sion, lung disease and cancer), history of exposure to COVID-19
infection (history of being diagnosed as COVID-19 case, inter-
action and household contacts with persons with confirmed
COVID-19), any history of COVID-19-related symptoms a
month before the survey and their self-reported compliance to
handwashing and use of face masks. Our Phlebotomists collected
5 ml of blood from each participant via venepuncture in a plain
vacutainer and transported to BBH laboratory (The Indian
Council of Medical Research (ICMR) and NABL (National
Accreditation Board for Testing and Calibration Laboratories)
accredited) within 5 h maintaining the cold chain.
Sample processing and analysis
The serum was separated and used to test for antibodies using the
Elecsys Anti SARS CoV2 assay, an electrochemiluminescent
immunoassay using a recombinant protein representing the
nucleocapsid (N) antigen for the determination of high-affinity
antibodies including IgG against SARS CoV2 [15]. This assay
employs a cutoff index (COI) that is automatically calculated
from two calibration standards – a COI of 1.0 or more is consid-
ered reactive/positive and a COI less than or equal to 1.0 is
reported as nonreactive/negative. Serum samples with indeter-
minate results were repeat tested and on with indeterminate
results on repeat testing were considered as negative. The assay
sensitivity and specificity were reported to be 97.2% (95.4–98.4)
Fig. 1. Aerial View of Devarajeevanahalli (DJ Halli) slum, Bangalore [1].
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and 99.8% (99.3–100), respectively, in samples taken 30 days or
more post-symptom onset [16].
Statistical analysis
The frequency of characteristics of the survey participants was
described. Seroprevalence of COVID-19 IgG antibody was reported
in per cent with 95% confidence interval (CI). Case-to-undetected-
infections ratio (CIR), was calculated as a ratio of the number of
reported quantitative real-time polymerase chain reaction
(RT-qPCR)-confirmed COVID-19 cases, 2 weeks before the initi-
ation of serosurvey (IgG antibodies against SARS-CoV-2 infection
start appearing by the end of the first week after symptom onset
and most cases are IgG positive by the end of the second week)
to the number of people who have IgG antibodies [17]. Assuming
a 3-week lag time from infection to death, we considered the
reported number of deaths after 3 weeks of the survey to estimate
the plausible range of the infection fatality ratio (IFR) [16]. It was
calculated as the number of deaths reported upon the total number
of people with IgG antibodies per 10 000 infections. The association
of seroprevalence with comorbid conditions and socio-demographic
characteristics was tested using chi-square tests.
Ethical consideration
The Ethics Committee on Bangalore Baptist Hospital approved
the survey protocol on 30 June 2020. Written informed consent
was obtained from the participants and the test results were com-
municated to them.
Results
Our 499 participants were equally distributed in both wards
(0.53% and 0.47%). The mean age was 39.7 + / 14.5 years and
the majority (74.3%) were females. Most people (96.9%) had
less than 12 years of education and 56.5% did not have any job.
About one-third of the population reported comorbidities (see
Table 1). Hypertension (19.2%) and diabetes (15.4%) were
reported as the most common comorbidities. The majority of
people reported frequent use of hand sanitisers (97.8%) and
face covers (88.4%).
The overall seroprevalence of IgG antibody for COVID-19 was
57.9% (95% CI 53.4–62.3) (Table 2). When we adjusted for the
sensitivity and specificity of the diagnostic kit the adjusted sero-
prevalence was 54.6% (95% CI 50.23–58.97). Seroprevalence
among participants with diabetes and hypertension was 62.3%
and 66.6%, respectively, but the association with seropositivity
was not significant. Among the seropositive individuals, 41.6%
had a history of an infected family member and 33.3% gave a his-
tory exposure to a COVID-19 infected person in the past. The
majority (95.2%) of the seropositive individuals, did not report
any symptom related to COVID-19 infection at the time of the
study nor in the past. This study estimated 195 undetected
infected individuals for every RT-PCR confirmed case, i.e. CIR
of 1:195. The IFR was calculated as 2.94 per 10 000 infections
as on 20 October 2020 in this slum.
Age, education, occupation, presence of comorbidities and
presence of self-reported symptoms were not associated with sero-
prevalence (P-value >0.05) whereas female gender was signifi-
cantly associated with seroprevalence.
Discussion
Our findings suggest very high COVID-19 seroprevalence in DJ
Halli slum. This is consistent with the study from Mumbai
slums, where a prevalence of 57% was noted 3 months past
index case. If we extrapolate our findings to the whole of DJ
Halli slum, 57 900 people in this slum would have contracted
the infection in contrast to 295 cases which were reported. This
is no surprise, as the hazardous physical environment, overcrowd-
ing, poor sanitation and the impracticability of social distancing,
hand washing and face covers in slums, are conducive for the
rapid spread of infection [18–22]. Another important learning
is that the vast majority of cases were asymptomatic. Hence,
they harboured and dispersed infection efficiently without being
caught by the tests or inviting medical attention.
A recent survey done in all 30 districts of Karnataka state, con-
ducted from 16 September 2020 among all adults aged 18 years
and above, reported adjusted IgG seroprevalence of 16.4% [23].
Though low (pregnant women attending the antenatal clinic),
moderate (persons moving in the community) and high risk (eld-
erly and persons with comorbid conditions) population group
were covered, the survey did not include population from slums,
a possible explanation for low prevalence. This study also esti-
mated that there were 40 undetected infected individuals for
every RT-PCR confirmed case, i.e. CIR of 1:40, ranged from 10
Table 1. Socio-demographic profile of the study population
Demographics Categories N %




Gender Male 128 25.7
Female 371 74.3
Education Illiterate 126 25.3
Primary to high school (⩽12
years of formal education)
357 71.6
Graduate 16 3.1
Occupation Unemployed 282 56.5
Domestic helper 38 7.6
Daily wage labourer 55 11
Professional 53 10.6
Others 71 14.2
Comorbidities Any comorbidities 159 31.9
Diabetes 77 15.4
Hypertension 96 19.2
Heart diseases 5 1.0
Others 20 4;0
Risk factors Tested positive for COVID 19 15 3.0
Family member tested positive
for COVID 19
12 2.4
Had an interaction with COVID 19
patient
9 1.8
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to 111 across units [23]. In the national seroprevalence survey con-
ducted by ICMR, the CIR was 81.6–130.1 in the first round (May)
[24]. Our CIR is higher than other surveys and can be attributed to
the low testing rates at the beginning of the epidemic.
Calculation of IFR is dependent on an accurate reporting of
deaths and the number of estimated infections. Reported IFR
may be an underestimate, as the real death due to COVID 19 is
likely to be more than reported deaths. The overall IFR based
on the serosurvey findings was much higher than that reported
from Santa Clara County, USA (0.12–0.2%), Iran (0.08–0.12%),
Brazil and Spain (1%) and of India in May [24–26]. This can
be explained by the differences in access to healthcare facilities,
quality of care and variation in the prevalence of comorbidities
A previous study in the same slum noted a higher prevalence
of hypertension (35.5%) and diabetes (16.6%) [8]. In that previous
study, the health professionals measured blood pressure and
blood sugar using a screening toolkit during a household survey.
The study showed a reported-actual discrepancy in comorbidity
prevalence, as more than half of the people with comorbidities
were detected during the study. People in slums are known to
have poor health-seeking behaviour; hence the actual proportion
of people with comorbidities may be higher than what we
reported in the current study.
The study participants reported improvement in hygiene
measures like hand sanitation and frequent use of face covers.
This may be due to improved behaviour following COVID-19
awareness campaigns led by the government and civic bodies
and mandatory workplace enforcement. The possibility of social
desirability bias (a discordance was noted as many were not wear-
ing masks though they labelled themselves as frequent mask users
during the survey) cannot be ruled out in this setting.
What does this ‘high seroprevalence’ mean to us? First and
foremost, it suggests that the worst is over. It is a relief to realise
that the virus spared most lives in this slum. With more than half
of the population already being infected, the infection curve is
likely to have started its journey down and COVID-19 will
cease to be a public health problem in DJ Halli. This is confirmed
by a low COVID-19 test positivity rate (1.5–2%) despite adequate
testing (2000 tests per million/day) from this slum in the past one
and half months (unpublished data from the government).
Likewise, we also did not see any suspected cases from our DJ
Halli clinic in the past 2 months. These findings provoke us to
rethink the need for a vaccine in this slum. If half the population
have antibodies, should we still call them vulnerable to
COVID-19? Is any vaccine a match for natural infection in
these settings? This study is not giving easy answers, but it does
give rise to such questions.
Second, the findings suggest it is time to shift our strategy from
chasing the virus’ to ‘mending the damages’; damages caused by
other diseases when COVID-19 annexed our undivided attention
and the damage caused by the loss of livelihoods. During the pan-
demic, the entire health system was reorganised to support to
pandemic response leading to scaling down and suspension of
disease control programmes, immunisation and primary health
care services. Due to fear, people postponed their hospital visits
for their non-communicable diseases and other life-threatening
conditions. Loss of jobs has aggravated hunger and nutritional
deprivation. In a survey by the WHO among 105 countries
around the globe, almost every country (90%) experienced a dis-
ruption to some extent, with greater disruptions being reported in
low- and middle-income than in high-income countries in essen-
tial health services across the life course [27]. We need to be cog-
nizant about the gravity of this situation in slums which struggled
with poor healthcare networks even before the pandemic and its
implications on public health in the coming months.
The pandemic was clearly a catch-22 situation in slums, where,
if people continued their life, as usual, they faced the risk of get-
ting infected. If they stayed at home as was being directed, they
lost their livelihoods and sources of sustenance. Hence, we shall
have to find ways to keep providing ‘regular’ healthcare to prevent
the consequences of trying to control the virus being more dam-
aging than the virus itself. This is especially relevant in settings
like this slum, where it is practically impossible to prevent the
spread of the virus.
The pandemic has also brought mercies. Slums have never
experienced so much attention and care as during this pandemic.
Every city highlighted their slums on their maps; we witnessed ‘miss-
ing millions’ becoming the ‘pinnacle of attention’. Government and
civic bodies formed alliances, crafted strategies, pooled in resources
to serve slums, thus attaining unbelievable progress on many
domains in the past 3 months [28].
The possibility of another pandemic and the vulnerability of
slums are stark realities in front of us. Had the mortality been
higher, the contagion would have wiped millions and the slums
would have been the reservoirs. Hence, we should take the lessons
from this pandemic seriously. The first step would be recognising
the slums and their inhabitants by improving basic living condi-
tions, facilitating stable economic inclusion and promoting access
to quality education and health services. Such investments in
slums will reap huge dividends due to neighbourhood effects
[29]. So, the COVID-19 pandemic is a wake-up call for govern-
ments to prioritise the humanity and dignity of residents of
urban slums and to engage with these communities and experts
to co-create solutions to promote the wellbeing of cities and its
population.
The study may have some potential biases. We have selected
different locations in the specific slum and then people were
invited for the study. This sampling might have led to selection
bias which could have impacted the true prevalence estimation.
However, we were not able to assess the impact of this on the
prevalence. Measurement bias could be another possibility due
to validity parameters of the test used, however, we attempted
to overcome this by reporting test performance adjusted sero-
prevalence rate with CI.
Table 2. COVID-19 seroprevalence in the study population
Category Male Prevalence (95% CI) Female Prevalence (95% CI) Total Overall prevalence (95% CI)
Age (years) ≤20 13 46.2 (19.2–74.9) 23 56.5 (34.5–76.8) 36 52.8 (35.5–69.6)
21–40 55 43.6 (30.3–57.0) 199 61.8 (54.7–68.6) 254 57.9 (51.5–64.0)
41–60 42 54.8 (38.7–70.2) 125 61.6 (52.5–70.2) 167 59.9 (52.0–67.4)
>60 18 44.4 (21.5–69.2) 24 62.5 (40.6–81.2) 42 54.8 (38.7–70.2)
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This is the first study reporting seroprevalence from a slum in
South India and the second study from India. It corroborates the
findings of the first study (peak attained within 3 months of index
case) and strengthens the body of evidence related to one of the
most vulnerable populations. It also gives guidance for the plan-
ners on allocating resources judiciously between COVID and
non-COVID care in the slums of India which harbour more
than 65 million people.
The study had few limitations. Firstly, the sampling strategy
emphasised more on pragmatism than representativeness in the
context of the communal violence which erupted in DJ Halli 2
weeks before the survey. Secondly, we have presented unadjusted
seroprevalence rate as there was no data available on the age-sex
distribution of this population. However, the estimates are very
likely to be close to the real estimate as the prevalence was almost
similar in all the strata. Thirdly, our sample had a smaller number
of men compared to women as they were not available at home
during the daytime. This might have resulted in an underestima-
tion of seroprevalence as men have more social contacts than
women in this context [24]. Fourthly, the study participants
were interviewed to collect information about the history of the
symptoms for the preceding month. However, as the presence
of IgG antibodies reflects exposure to COVID 19 since the begin-
ning of the pandemic, we were not able to estimate how many
seropositive individuals ever had probable COVID-19 symptoms.
Lastly, since we have not done RT-PCR or IgM antibodies separ-
ately, we would have missed people who were currently harbour-
ing infection, resulting in a slight underestimation of the
prevalence.
Conclusion
The study in a dense slum in South India after 3 months of index
case showed a high seroprevalence of COVID-19 infection in this
setting. For every case reported, there were 195 undetected cases,
which unearths the implication of the often-asymptomatic nature
of the disease in reflecting the true count of people with
COVID-19 infection. Vulnerability to infection is the primary
condition to assign priority for COVID-19 vaccination, due to
vaccine demand exceeding our existing capacity of vaccine pro-
duction. Hence, we should keep in mind the possibility of most
vulnerable communities achieving immunity with natural infec-
tion, thus negating the benefit of the vaccine in this population.
The process of carrying out a seroprevalence study in dense set-
tlements before vaccination may prove advantageous in identify-
ing the disadvantaged communities which will benefit most from
vaccination.
It is vital to realise that containing an infectious respiratory
virus was practically impossible in slums, even with the best of
efforts from all sectors. Slums received attention and coordinated
efforts from government and civic societies during this pandemic,
which is containing the damage caused by the pandemic. We
should nurture these networks beyond the pandemic to
strengthen health security of slums and their inhabitants.
Since the infection is controlled in slums like DJ Halli, what is
the way forward – ‘hands-off’ or ‘all hands on the deck approach?’
The answer lies in the wisdom – that the debate should not only
be about the virus but more importantly, about the people living
in slums!
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